Genprex Shares Plunge Amid Heavy Selling Pressure
Published on 10/04/2025 at 08:54 | Redaktion boerse-global.de
Genprex shares continue their downward trajectory, marked by significant price declines and surging trading activity. Technical indicators point to sustained selling momentum, leaving investors to wonder when this bearish trend might find a floor.
The biotech company’s stock extended its losing streak yesterday, dropping another 2.5% amid heavy trading. This latest decline contributes to a substantial 18.20% loss recorded over just ten trading sessions, with seven of those days closing in negative territory.
Market volatility reached extreme levels during yesterday’s session, with prices swinging between $0.175 and $0.2096—representing an intraday fluctuation range of 19.77%. These wild price movements underscore significant investor uncertainty about the company’s near-term prospects.
Volume Surge Confirms Bearish Sentiment
Trading volume tells a... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
